Data / Form D filings / Acenxion Biosytems, Inc.
Acenxion Biosytems, Inc.: Form D filings
Acenxion Biosytems, Inc., a biotechnology company in Lawrence, KS, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on August 14, 2024, reports $1.1 million sold of a $1.1 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2029 BECKER DRIVE, SUITES 225 & 227, Lawrence, KS, 66047
- Phone
- (321) 749-0523
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1974107
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | New notice | $1,070,000 | $1,070,000 | 5 | Jul 19, 2024 | sec.gov | |
| Apr 18, 2023 | New notice | $2,000,023 | $50,000 | $1,950,023 | 1 | Apr 1, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Howard Goldstein | Director | |
| Brian Struchtemeyer | Executive Officer, Director | |
| Roy Swiger | Executive Officer, Director | |
| Wayne Carter | Director |
Every Form D from the week of Aug 12, 2024 · All recent filings in Kansas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Acenxion Biosytems, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.